-
03-07-2020, 12:51 PM
#17791
Pretty handsome return for those who subscribed to Rights issue at 10c towards end of last year. But again their original purchase price might've been lot higher than that.
Hence, we might see lot of profit taking in the short term as those holders would like to lock in some gains.
Also, it would've been helpful if they've quantified the value of total reimbursements.
-
03-07-2020, 12:58 PM
#17792
Junior Member
Anyone know anything about Cxcolorectal or even other tests being developd? It's on their website but I don't recall them being mentioned.
https://www.pacificedgedx.com/products/pipeline/
-
03-07-2020, 01:16 PM
#17793
Member
Originally Posted by sb9
Also, it would've been helpful if they've quantified the value of total reimbursements.
Page 13 of the annual report:
"As at 31 March 2020, a total of 21,789 tests have been performed that relate to patients covered by CMS, for which no payments have been received and no revenue recognised."
This is approx 21,789 x US$760 = NZ$25,439,084.
There's other tests conducted via private insurance which I assume aren't affected by this decision and PEB will have to continue chasing.
-
03-07-2020, 01:20 PM
#17794
Member
Originally Posted by Longhaul
Page 13 of the annual report:
"As at 31 March 2020, a total of 21,789 tests have been performed that relate to patients covered by CMS, for which no payments have been received and no revenue recognised."
This is approx 21,789 x US$760 = NZ$25,439,084.
There's other tests conducted via private insurance which I assume aren't affected by this decision and PEB will have to continue chasing.
Not a bad windfall!That should at least quell the need for any capital raise short term
-
03-07-2020, 01:23 PM
#17795
Originally Posted by Longhaul
Page 13 of the annual report:
"As at 31 March 2020, a total of 21,789 tests have been performed that relate to patients covered by CMS, for which no payments have been received and no revenue recognised."
This is approx 21,789 x US$760 = NZ$25,439,084.
There's other tests conducted via private insurance which I assume aren't affected by this decision and PEB will have to continue chasing.
Yep, the cashflow problem just disappeared. Let alone all the new tests that will start to flow in. "Tens of thousands" rings a bell from the history of projections for the company.
-
03-07-2020, 01:25 PM
#17796
Member
Have the shareholders just arrived in the promise land....
-
03-07-2020, 01:27 PM
#17797
Originally Posted by nevchev
Not a bad windfall!That should at least quell the need for any capital raise short term
Interesting. I feel a Capital raise would allow them more cash for developing customer channels ... I say, raise more capital and go for gold ... release the hand brake, take flight.
Don't want to sit around waiting for another 10 years ...
Pretty happy today ... well done holders.
I recently jumped in as I believe in the product. Exceptional potential. I'd be keen for a Capital Raise
-
03-07-2020, 01:30 PM
#17798
Originally Posted by Balance
LCD coverage received most likely.
Or takeover by John Hopkins?
Or law suit for misdiagnosis?
Take your pick!
Gone quiet after this post Balance...either off buying up as many as you can (if you haven't already) or preparing to eat that big slice of humble pie.
It took a while - but am so pleased for PEB (& its LONG TERM shareholders) this day has finally arrived. DD & Co deserve to have their day in the sun ... my best wishes to all of them.
-
03-07-2020, 01:39 PM
#17799
Originally Posted by Food4Thought
Interesting. I feel a Capital raise would allow them more cash for developing customer channels ... I say, raise more capital and go for gold ... release the hand brake, take flight.
Don't want to sit around waiting for another 10 years ...
Pretty happy today ... well done holders.
I recently jumped in as I believe in the product. Exceptional potential. I'd be keen for a Capital Raise
Why would you raise more cash when you have from memory 15 million in the bank and another 25m coming from back payments? The lab is already in place in the States. I suspect they might want some more sales reps, although they have already increased this prior. Hopefully not much expense involved in scaling up from here.
-
03-07-2020, 01:43 PM
#17800
Originally Posted by Dentie
Gone quiet after this post Balance...either off buying up as many as you can (if you haven't already) or preparing to eat that big slice of humble pie.
It took a while - but am so pleased for PEB (& its LONG TERM shareholders) this day has finally arrived. DD & Co deserve to have their day in the sun ... my best wishes to all of them.
Very easy pie to eat - with champagne & Catham Island lobster, Dentie.
I am very pleased for the long suffering remaining shareholders of PEB and I wish PEB & them well.
Read through my posts of the last few weeks and I believe you will see me acknowledging that things are changing for them.
NZ needs success stories for our future generations to be inspired and aspire to achieve. There are some very valuable lessons to be learnt from how PEB has gone about commercializing CxBladder, and I hope the lessons are learnt.
Tags for this Thread
Posting Permissions
- You may not post new threads
- You may not post replies
- You may not post attachments
- You may not edit your posts
-
Forum Rules
|
|
Bookmarks